galactose has been researched along with theanine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 3 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gong, Z; Lin, L; Peng, Y; Xiao, W; Yuan, D; Zeng, L; Zhang, S | 1 |
| Chen, L; Gong, Z; Lin, L; Xiao, W; Zeng, L | 1 |
| Li, Y; Lin, L; Xiao, W; Zeng, L | 1 |
3 other study(ies) available for galactose and theanine
| Article | Year |
|---|---|
l-Theanine attenuates liver aging by inhibiting advanced glycation end products in d-galactose-induced rats and reversing an imbalance of oxidative stress and inflammation.
Topics: Aging; Animals; Antioxidants; Galactose; Glutamates; Glycation End Products, Advanced; Inflammation; Liver; Liver Diseases; Male; Oxidation-Reduction; Oxidative Stress; Rats; Rats, Sprague-Dawley | 2020 |
l-Theanine Ameliorates d-Galactose-Induced Brain Damage in Rats via Inhibiting AGE Formation and Regulating Sirtuin1 and BDNF Signaling Pathways.
Topics: Animals; Brain Damage, Chronic; Brain-Derived Neurotrophic Factor; Galactose; Glutamates; Glycation End Products, Advanced; Male; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Sirtuin 1 | 2021 |
L-theanine protects rat kidney from D-galactose-induced injury via inhibition of the AGEs/RAGE signaling pathway.
Topics: Animals; Galactose; Glutamates; Glycation End Products, Advanced; Inflammation; Kidney; Oxidative Stress; Rats; Receptor for Advanced Glycation End Products; Signal Transduction | 2022 |